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ABSTRACT
Background: Extremity bone and soft tissue sarcoma are a rare type of cancer with
treatment modalities to include chemotherapy and radiation and surgical procedures.
Surgery can be limb salvage or limb amputation. Patients of extremity bone and soft
tissue sarcomas may experience physical and psychosocial effects due to sarcoma
treatments impacting physical performance, quality of life, and social support. Therefore,
this study sought to evaluate the complications of extremity bone and soft tissue sarcoma
in patients following limb salvage and amputation surgeries.
Methods: Patients were selected from the University of Minnesota Fairview Hospital
database and had a primary tumor located in the lower extremity. A medical chart review
was conducted and complications encountered by bone and extremity soft tissue sarcoma
patients were reviewed and recorded.
Results: Local recurrence was greatest in limb salvage reconstruction, n=10 (20%)
compared to amputation reconstruction n=1 (2%). Infection was greatest in the limb
salvage group, n=8 (16%) versus amputation group, n=2 (4%). Physical limitations were
reported in 95% of the limb salvage patients and 100% of the amputation patients. Pain
was reported in all the 50 patients. Nineteen patients (38%) in limb salvage group and
twenty-five patients (50%) in amputation group had revision surgeries. Cardiomyopathy
induced by anthracycline treatment was reported in three patients. One patient had
sensorineural hearing loss due to high dose methotrexate exposure.
Conclusions: Extremity bone and soft tissue sarcoma patients can suffer long term
effects from their surgical and chemotherapy or radiation treatment. Local recurrence,
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infection, pain, physical limitations are some of the complications arising from such
treatments which can impact their quality of life. Limb salvage group had a greater local
recurrence and infection rate than the amputation group. Therefore, amputation was not
associated with greater post-surgical complications than limb salvage.
Keywords: Extremity bone and soft tissue sarcoma, complications, limb salvage surgery,
and amputation.
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Chapter 1: Introduction
Introduction
Bone and soft tissue sarcomas are very rare and account for less than 2% of all
adult cancers in the world (Paredes, Pereira, Moreira, Simões & Canavarro, 2011). The
treatment of choice is limb salvage surgery, or limb amputation with chemotherapy, or
radiation (Paredes et al., 2011). Patients can have either chemotherapy or radiation and
this is dependent on the standard of care of the sarcoma. When compared to other
cancers, little information is known regarding the complications of standard treatment of
sarcoma. Patients and survivors generally experience lifelong effects from treatment and
may not be able to return to their baseline function (Paredes et al., 2011). This chapter
will cover the background information about sarcomas, problem statement, purpose of
the study, research question, significance of the problem, limitations of the study and
definition of terms.
Background Information
Studies have examined the complications faced by extremity bone and soft tissue
sarcoma patients following treatment. Wide resection of the tumor is important to achieve
negative margins and limb salvage reconstruction may present with reconstructive
complications (Papanastasiou et al., 2016). Complications of limb salvage reconstruction
include infection, mechanical failure, and local recurrence (Papanastasiou et al., 2016).
Infection following a limb salvage procedure can lead to serious complications that can
result in amputation. The common pathogens causing infection are staphylococcus and
streptococcus species (Lee, OH, Lee, Yoo, & Kim, 2002). However, some rare pathogens
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have been identified. Leishmania infection of a distal femoral megaprosthesis in a patient
treated with limb salvage of distal femoral osteosarcoma resulted in sepsis and ultimately
death (Papanastasiou et al., 2016).
Reconstruction procedures in children is more complicated by the loss of physis
(Ruggieri, Mavrogenis, Pala, Romantini, Manfrini, & Mercuri, 2013). Most tumors occur

in the metaphyseal region and limb salvage reconstruction can result in leg length
discrepancies. Expandable endoprosthesis have been developed to address the issue of leg
length discrepancies (Cipriano, Gruzinova, Frank, Gitelis, & Virkus, 2015). Expandable
endoprosthesis is used mostly for tumors of the distal femur, proximal tibia, and proximal
humerus. The disadvantage of this type of reconstruction is that many pediatric patients
will require revision in the first 5 years due to complications.
Amputation is usually recommended when no negative margins can be obtained
after tumor resection or when the tumor has invaded vascular structures and a limb
salvage procedure would not result in a functional limb (Levin, Arkader, & Morris 2017).
Amputation occurs in about 10% of cases. Complications of amputation include physical
limitations due to increased oxygen demand during activities such as walking (Levin et
al., 2017). Amputation often leads to phantom pain, bleeding, infection, bone overgrowth
at the amputation site (Levin et al., 2017)
Problem Statement
While research has been conducted on the complications following sarcoma
treatments for bone and soft tissue, there has been limited research in Minnesota. Bone
and extremity soft tissue sarcoma treatment usually includes chemotherapy or radiation,
and surgery (Paredes et al., 2011). Surgery can be limb salvaging or amputation. Bone
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and extremity soft tissue sarcoma patients who undergo surgery may need to rebuild the
bone and joint and more than one surgery may be needed in order to optimize function of
limb. Joint pain and discomfort may be constantly lifelong for patients with bone or
extremity soft tissue sarcoma such that ongoing physical therapy is needed. Participation
in strenuous or athletic activity may also be limited following surgical procedure.
Studying the complications of sarcoma patients and survivors who have undergone
chemotherapy/radiation and limb salvaging or amputation surgery is important in order to
determine how the diagnoses and treatments have altered their lives.
Purpose
Although various research studies have demonstrated that treatment of extremity
soft tissue and bone sarcoma do result in complications, much research is based on bone
sarcoma. This research aims to detail the different types of complications that both
extremity bone and soft tissue sarcoma patients face. The purpose of this study is to
evaluate the complications of sarcoma treatments through medical chart review.
Research Questions
1. For extremity sarcoma patients treated with tumor excision, is amputation associated
with greater post-surgical complications compared to a limb salvage procedure?
2. Is there a difference in post-surgical complications for patients who had an amputation
versus limb salvage procedure?
Significance of the problem
Patients with bone and extremity soft tissue sarcoma may experience lifelong
effects such as physical, emotional, and psychological harm from their treatments.
Although the extent of the complications resulting from the limb salvage and amputation
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procedures have been documented in literature, we need to understand the complications
patients and survivors face in Minnesota. We cannot underestimate the impact of cancer
treatment on the patients and their families. Therefore, ongoing support to optimize the
patient`s function is needed. To avoid stagnation or decline in function, health care
providers have a responsibility of educating, encouraging, and ordering relevant
treatments. In addition, the importance of social, emotional and psychological support
cannot be underestimated, this makes a difference in mental stability.
Limitations of the Study
The most significant limitation is obtaining a large enough sample size to review
their medical records due to the rarity of sarcoma diagnoses. This may have an impact on
the success of doing a comprehensive review on the complications faced by sarcoma
patients.
Definition of Terms
The following definition of terms are core in understanding the purpose of study:
Sarcoma “is a type of cancer that develops from certain tissues like bone or
muscle. Bone and soft tissue sarcomas are the main types. Soft tissue sarcoma arises from
fat, muscle, nerves, fibrous tissue, blood vessels or deep skin tissues”
Bone sarcoma “is a type of cancer that starts in the bone” (American Cancer
Society, 2015)
Extremity soft tissue sarcoma is “a soft tissue sarcoma of the extremities”
(American Cancer Society, 2015)
Cancer survivor is “someone who has been free of any sign of the disease for 5
years” (American Cancer Society, 2015)
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Limb salvage is a surgical technique in which there is limb sparing resection after
tumor removal (Paredes et al., 2011)
Limb amputation is a surgical technique in which there is total limb removal
(Paredes et al., 2011)

6

Chapter 2: Review of Literature
Sarcoma
Sarcomas are a tumor of the connective tissue and comprise a diverse group of
mesenchymal neoplasms (Skubitz & D’Adamo, 2007). Sarcomas can be classified into
two categories: soft tissue and bone. Patients may present with an asymptomatic mass or
pain if the tumor distorts normal structure (Skubitz & D’Adamo, 2007). Biopsy is
performed to obtain tissue for diagnoses of sarcomas. Care is taken when performing a
biopsy in order not to interfere with subsequent surgery to remove the whole tumor
(Skubitz & D’Adamo, 2007).
Bone Sarcoma
Bone sarcomas originate from the bone cells or bone cell precursors (Mavrogenis
& Ruggieri, 2015). Bone sarcomas have a potential for metastases, especially to the
lungs. The majority of bone sarcomas are diagnosed in children and young adults,
although older adults and elderly may also develop bone sarcomas (Mavrogenis &
Ruggieri, 2015). The most common type of bone sarcoma is Osteosarcoma (Ferrari,
Balladelli, Palmerini, & Vanel, 2013), and the second most common type of bone
sarcoma is Ewing Sarcoma Family Tumors (EFT). Ewing Sarcoma Family Tumors is
usually diagnosed in children, adolescents, and young adults (Ferrari et al., 2013).
Chondrosarcoma is the third most common bone sarcoma diagnosed mostly in the 3rd to
the 6th decade of life (Mavrogenis & Ruggieri, 2015).
Bone sarcomas usually develop in the extremities, especially the long bones
(Skubitz & D’Adamo, 2007). Patients with bone sarcoma usually present with pain,
swelling, or functional impairment. A bone sarcoma tumor can also be identified
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following radiography in incidences of fracture or trauma (Ferrari et al., 2013). Magnetic
resonance imaging (MRI) is the primary imaging method for evaluation of bone tumors
(Ferrari et al., 2013).
Once imaging has been completed, an orthopedic surgeon performs a biopsy and
the subsequent pathologic findings makes the diagnoses (Ferrari et al., 2013). Biopsy can
be closed (core needle biopsy-image guided) or open (surgery biopsy). Core needle
biopsy-image guided involves using a large introducer gauge needle, advancing it to the
proximal margin of tumor and then a smaller core biopsy needle (cutting needle) to
obtain tissue sample for pathology testing (Kachroo et al., 2012). Open surgical biopsy
involves making an incision where the tumor is located and taking out tissue sample
(Kachroo et al., 2012). Open surgical biopsy is often indicated because a large sample
size tissue can be obtained for further studies such as cytogenetics. Risks associated with
open surgical procedure are infection, bleeding, scarring or inflammation.
Treatment of bone sarcomas involves chemotherapy and/or radiation. Patients
then undergo limb sparing or amputation procedures (Ferrari et al., 2013). The patient is
preferentially treated with chemotherapy prior to surgical treatment in order to treat
potential metastases and to reduce tumor size allowing for easier resection (Mavrogenis
& Ruggieri, 2015).
Osteosarcoma Excision
The primary osteogenic malignant tumor is rare and represents less than 4% of
cancers in children under the age of 14 (Gurney, Scott, Severson, Fang, Robison & Ross,
1996). The traditional standard treatment following chemotherapy is wide excision of the
bone with 2-3 cm margins in order to prevent local recurrences (Chen, Wu, Chen, Chung,
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Liu, & Chen, 2012). Wide excision should achieve histologically negative margins
(National Comprehensive Cancer Network, 2016). However, the limb resection sacrifices
healthy bone and may have an impact on joint function (Chen et al., 2012). Important
surrounding tissues such as ligaments, menisci, and articular cartilages may be resected if
they are invaded by the tumor or to prevent local recurrences. In a small number of
patients, hemicortical resection with biological reconstruction using frozen autograft and
fresh-frozen allograft is a potentially successful treatment for patients with high-grade
osteosarcoma (Chen et al., 2012). Autograft is the patient`s own bone and allograft is
bone from donor. Patients had better limb functionality and minimal complications with
hemicortical resection. Hemicortical resection is possible only in patients with a small
tumor volume, appropriate tumor margin and good response to chemotherapy (Chen et
al., 2012). The type of tumor excision has an impact on the functionality of the
reconstructed limb and careful consideration of the surgical treatment by both patient and
surgeon is required.
Chemotherapy and Radiation
Chemotherapy remains the treatment of choice in bone sarcoma (Arndt & Crist,
1999). Chemotherapy has improved the prognosis of children with osteosarcoma since
the 1960s and the five-year survival rate in non-metastatic sarcoma is approximately 6070% (Skubitz & D’Adamo, 2007). In the past, prior to neoadjuvant chemotherapy,
survival rate was 20% due to distant metastases (Skubitz & D’Adamo, 2007). In addition,
adjuvant chemotherapy has proven to be effective in reducing metastases and local
recurrences especially in osteosarcoma (Skubitz & D’Adamo, 2007). The first
randomized controlled trial showing the benefit of adjuvant chemotherapy in
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osteosarcoma was conducted by Link, et al. (1986). Two years following adjuvant
chemotherapy, 66% of patients who had received adjuvant chemotherapy had no
recurrences compared to 17% from the group that did not receive adjuvant treatment.
Based on this study, adjuvant chemotherapy has been the standard of care in treating
osteosarcoma in addition to surgical treatments. Survival rates have been increased
compared to surgical treatments alone due to relapse prevention.
According to the National Comprehensive Cancer Network guidelines (2016), the
chemotherapy drug recommended for osteosarcoma includes one of three first line
regiments: 1. cisplatin, doxorubicin, and high-dose methotrexate, 2. cisplatin,
doxorubicin with or without ifosfamide and ifosfamide, cisplatin, and epirubicin. The
clinical significance for multi-agent chemotherapy regimen for bone sarcoma has been
discussed by Subbiah, Anderson, Lazar, Burdett, Raymond and Ludwig, (2009). The
alkylating agents (cisplatin and doxorubicin) contribute to severe late side effects such as
leukemia or anthracycline-induced cardiomyopathy (Arndt & Crist, 1999). Vincristine,
doxorubicin, cyclophosphamide, and actinomycin D combination treatments are indicated
for Ewing sarcoma. Chondrosarcoma, which are malignant cartilaginous tumors are
considered chemotherapy and radiation resistant and surgery is the treatment of choice
(Harwood, Alexander, Mayerson, & Scharschmidt, 2015). Neoadjuvant radiation therapy

may be indicated for patients with chondrosarcoma of the skull base and axial skeleton in
which the tumor is located in a place difficult for resection (Gelderblom, Hogendoorn,
Dijkstra, Van Rijswijk, Krol, Taminiau, & Bovee, 2008).
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Extremity Soft Tissue Sarcoma
Soft tissue sarcomas are rare malignant tumors originating from “fat, muscle,
nerves, fibrous tissue, blood vessels or deep skin tissues” (American Cancer Society,
2015). The most common site for soft-tissue sarcomas in the extremities are in the lower
limbs (Beckingsale & Shaw, 2015). While bone sarcomas are common in childhood, soft
tissue sarcomas are common in adulthood, especially in persons 50 years old and older.
The first line therapy for large, high-grade, soft tissue sarcoma is surgery followed by
radiation therapy (Skubitz & D`Amano, 2007). Small, low-grade tumors can be treated
with surgery alone. Chemotherapy may be used to shrink the soft tissue tumors before
and after surgery to prevent recurrences, and the chemotherapy agents which are used are
doxorubicin and ifosamide (Skubitz & D`Amano, 2007).
Reconstruction and Complications
Patients with bone and extremity soft tissue sarcomas may need to undergo limb
sparing or amputation surgery (Wang et al., 2015). Amputation is indicated if a
functionally viable extremity and negative margins cannot be obtained (Mavrogenis &
Ruggieri, 2015). Reconstruction of the limb after malignant tumor removal, in particular
around the knee, is difficult because wide excision is performed so that histologically
negative margins are obtained minimizing local recurrence (Wang et al., 2015). In
addition, reasonable functional expectations of the limb have to be achieved. Methods for
reconstruction include tumor prosthesis, biological reconstruction with osteochondral
autograft and allograft, frozen autograft-prosthesis or bone prosthesis composite (Wang
et al., 2015; Chen et al., 2012; Yoshida, Osaka, Kojima, Taniguchi, Osaka, & Tokuhashi,
2012). Bone prosthesis composite (BPC) with rotating hinge knee prosthesis for
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reconstruction following resection of the knee showed excellent durability for the first
five years with minimal complications (Wang et al., 2015). In biological reconstruction,
bone allografts are used and obtained from a bone bank. For an osteochondral autografts,
a surgeon harvests a bone graft from the patient section of bone that does not have the
tumor and transplants it into the area where the excised tumor was present.
Tumor prosthesis remains the primary treatment because it allows for stable limb
function (Yoshida et al., 2012). However, complications may arise including infection, or
the prosthesis stem breaking or loosening necessitating revision (Yoshida et al., 2012).
Tumor prosthesis is an artificial implant that is used to replace the excised bone during
tumor resection. Following tumor prosthesis, seven (17.5%) out of forty patients reported
stem breakages or loosening necessitating revision surgery (Yoshida et al., 2012).
Infection rates were reported to be 6% in 104 osteosarcoma patients who had undergone
neoadjuvant chemotherapy and reconstruction surgery with tumor prosthesis (Bi, Wang,
Han, Jia, & Xu, 2013). Infection is related to bacteria growing in biofilms on the implant
especially the Staphylococci specie. Suggestions to minimize stem breakage or loosening
following tumor prosthesis have been to limit resection of the affected bone to not greater
than 30% and using a prosthesis with a thicker stem of at least 12 mm (Yoshida et al.,
2012).
Frozen autograft-prosthesis composite reconstruction is preferable for malignant
bone tumors of the proximal humerus, tibia, and pelvis which allows for optimal softtissue reattachment to the prosthesis (Subhadrabandhu,et al., 2015). One of the
procedures for frozen autograft-prosthesis involves free freezing the tumor bearing bone
in liquid nitrogen for 20 minutes, thawing for 15 minutes at room temperature and then in
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distilled water for ten minutes (Subhadrabandhu,et al., 2015). The advantages of frozen
autograft include biological reconstruction without the need for a bone bank and no
immunological reactions or possibility of disease transmission from donor bone.
However, there are disadvantages, mainly fracture and infection. Frozen autograftprosthesis composite reconstruction performed in 22 patients and followed up for an
average of 14.7 years resulted in one fracture, two infections, three soft tissue
recurrences, and one posterior interosseous nerve palsy (Subhadrabandhu et al., 2015).
The average Musculoskeletal Tumor Society score (MSTS) was high, 89.3% which
suggested frozen autograft-prosthesis composite reconstruction may be highly
recommended in certain malignant bone tumors. Musculoskeletal Tumor Society score is
a measure of physical function for patients of bone sarcomas.
There are complications that arise with limb salvage reconstruction (Shehadeh,
Noveau, Malawer, & Henshaw, 2010). Generally, patients are having longer survival
rates and usually outlive the functional life of the endoprosthesis implants. Complications
that arise later include breakage or fracture of implant, instability due to wear, and
infection. Patients usually require revision surgeries thereafter and that also increases the
risk of infection of the implant and incision wound. Shehadeh et al. (2010) found that
rates of complications increased with each successive revision surgery. They also
attributed implant failure to mechanical complications such as implant loosening. In
addition, infection led to amputation in some patients.
Amputation is usually above-knee amputation or hip disarticulation due to most
tumors occurring on the proximal femur or tibia (Li, Wang, Ji, Chen, Liu, & Zhu, 2010).
Above knee amputation often leads to less favorable psychosocial outcomes.
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Rotationplasty is available as a means to effectively convert an above-knee amputation to
a below-knee amputation for certain tumors. During rotationplasty, the distal femur and
proximal tibia are resected and distal tibia and foot are rotated 180o. Tibiofemoral
osteosynthesis occurs, and distal tibia augments to femur. The reversed ankle operates as
the knee and prosthesis fits on foot. Patient functions as a below knee amputee (Li et al.,
2010).
Quality of Life
A bone sarcoma and extremity soft tissue sarcoma diagnoses can have devastating
outcomes which affect the quality of life. Reconstruction surgery following limb
resection can affect the functionality of the limb (Sachsenmaier et al., 2015). Some
patients may not qualify for limb salvage surgery leading to limb amputation. Mason et
al. (2013) found that cancer survivors who had limb preservation surgery had statistically
significant superior quality of life than survivors who had amputation surgery in several
domains such as: Material well-being, occupational relations, job satisfaction, and sports
activity. Sachsenmaier et al. (2015) were able to study the impact of psychological
therapy, family, social and educational background, occupation, and physical status on
the quality of life after sarcoma diagnoses. The researchers found the presence of family
and social support, psychological therapy and better physical status contributed to better
quality of life and survivors who could still work at their jobs after treatment showed
better emotional status.
Osteosarcoma survivor’s psychosocial and functional outcomes were compared
after limb-salvage surgery and amputation. The greatest predictor on the quality of life
was the functionality of lower limb, not surgery type (Robert, Ottaviani, Huh, Palla, &
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Jaffe, 2010). Limb amputation affected body image and quality of life when performed
after failed limb salvage surgery (Robert et al., 2010). Thijssens, Hoekstra-Weebers, Van
Ginkel, and Hoekstra, (2006) studied the quality of life as it related to post-traumatic
stress symptoms (PTSS) in patients with extremity soft tissue sarcoma. The patient selfreported on their physical functioning, social functioning, role impairment due to
physical problems, mental health, vitality, pain, general health perception and health
change (Thijssens et al., 2006). Patients who were more satisfied with their treatment
goals reported less PTSS and had a better QOL (Thijssens et al., 2006). In addition,
patients with an amputated limb had a worse quality of life score in physical and social
functioning and role limitations (Thijssens et al., 2006).
Summary
Bone and soft tissue sarcomas are very rare. The survival rates have increased
since the incorporation of neoadjuvant chemotherapy in the treatment protocol. Limb
sparing and amputation surgeries have an impact on the functionality of the limb and may
affect physical status and unexpected complications. This research is focused on studying
the complications following limb salvage and amputation procedures by conducting a
medical chart review.
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Chapter 3: Methodology
Introduction
The purpose of the research was to evaluate the complications of extremity bone
and soft tissue sarcoma patients who have undergone surgical resection of their tumor.
There are two research questions for the study:
1. For extremity sarcoma patients treated with tumor excision, is amputation associated
with greater post-surgical complications compared to a limb salvage procedure?
2. Is there a difference in post-surgical complications for patients who had an amputation
versus limb salvage procedure?
Study Design
This study’s design is that of a quantitative chart review. A retrospective review
of 50 medical records was done for patients who underwent limb salvage reconstruction
and amputation between 1995 and 2014. The musculoskeletal tumor computerized
database at the University of Minnesota of patients who had limb salvage and amputation
reconstruction was reviewed. Complications were classified as infection, revision
surgeries, recurrences, mechanical failure of implant, physical limitations.
Study Participants
The entry criteria for the study participants was:1) diagnosis of bone or soft tissue
sarcoma, 2) current age > 18 years, 3) male or female, 4) surgical resection of sarcoma of
the extremity, 5) chart review > 2 years after index surgery.
Data Collection
Data collection included demographic and treatment related data of the study
participants. Demographic data was: 1) age of patient at time of diagnosis, 2) date of
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birth, 3) diagnosis, 4) date of diagnosis, 5) tumor site: bone: pelvis, proximal femur,
distal femur, proximal tibia, distal tibia, fibula, distal fibula, proximal humerus, distal
humerus, forearm, hand, other; soft tissue: buttock, thigh, leg, hindfoot (calcaneus,
talus), midfoot/forefoot (cuboid, navicular, cuneiforms, metatarsals, phalanges), arm,
forearm, hand/wrist.
Treatment information included: 1) surgical procedure: reconstruction [soft tissue,
prosthesis or structural bone graft, and plastic surgical (e.g, muscle flap or skin graft)],
amputation (partial foot, below knee, above knee, hip disarticulation, hemipelvectomy,
above elbow, below elbow, shoulder girdle), 2) surgery date, 3) chemotherapy: cytotoxic
(total duration relative to surgery date), 4) radiation: total dose (Gy), 5) additional
surgery and date.
Relevant Variables
Independent variables were study population: extremity bone sarcoma and
extremity soft tissue sarcoma patients. Dependent variables complications, amputation vs
limb salvage.
Storage of Data
The patient completed demographic data form was kept on the Fairview password
protected encrypted computer drive at the University of Minnesota Orthopaedic
Department for a period of five years. The medical chart review was conducted on the
Fairview computer.
Limitations of study
Bone and extremity soft tissue sarcoma are a rare type of malignancy and the
results of the study was confounded by small sample size.

17

Statistical Analysis
Statistical analysis was carried out using IBM® SPSS® for windows. Unpaired ttest was done to determine the mean difference between the complications scores for
amputation group versus limb salvage group. An unpaired t-test was done to determine
the mean difference in the complication scores between the amputation versus
amputation after limb salvage procedure.
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Chapter 4: Results
Demographic Data
The data collection included sex, age at diagnosis, current age, type of sarcoma,
site of the primary tumor, surgical treatment, chemotherapy/radiation, and revision
surgeries.
All the patients included in the medical chart review were 2 years post sarcoma
diagnosis and treatment. There were 50 medical chart reviews.
The following table shows the range, median and average age at diagnosis and current
age
Table 1.0: Current age and age at diagnosis
Age at diagnosis (years)

Current age (years)

Median

23.6

45

Mean

29.7

45.8

Range

7-62

22-71

Type of Sarcoma
Osteosarcoma and Ewing sarcoma were diagnosed in childhood. The tumors
occurred mostly in the tibia and femur. The malignant tumors that occurred in the distal
tibia and femur were associated with above the knee amputation if amputation was
indicated. The most common bone sarcoma in adults was malignant fibrous histiocytoma
and chondrosarcoma. For extremity soft tissue sarcoma, synovial, neurofibrosarcoma,
peripheral nerve sheath sarcoma, clear cell sarcoma were diagnosed in adults.
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Table 2.0: Type of sarcoma diagnosis and common sites of primary tumor (n=50)
Bone or soft tissue sarcoma of

Site of primary tumor

# patients

Osteosarcoma

Tibia, femur

16 (32%)

Ewing sarcoma

Tibia, femur, foot bone

9 (18%)

Chondrosarcoma

Femur, thigh

7 (14%)

Peripheral nerve sheath sarcoma

Antecubital region, posterior

4 (8%)

extremity

thigh, leg
Pleomorphic sarcoma

Tibia and patella

1 (2%)

Desmoplastic small round cell tumor Radius

1(2%)

Epithelioid sarcoma

Femur

1(2%)

Neurofibrosarcoma

Calf, ankle

2 (4%)

Clear cell sarcoma

Foot bone

1 (2%)

Synovial sarcoma

Ankle, foot bone, midfoot

3 (6%)

Malignant fibrous histiocytoma

Femur, elbow, leg and calf

3 (6%)

Angiosarcoma

Leg and knee

1(2%)

Leimyosarcoma

pelvis

1(2%)

Most of the patients were diagnosed with a malignant tumor located in the lower
limbs, n=45. There were patients whose tumor was in the upper limb, n=4 and pelvis,
n=1. Forty-seven of the patients had localized disease and three had metastases at the
time of diagnosis. Nineteen patients had limb salvage reconstruction, twenty-five patients
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had amputation and six patients had amputation after failed limb salvage. Amputation
after failed limb salvage reconstruction was due to infection of the endoprosthesis, bone
allograft and local recurrence.
Treatment Protocols
Forty-three patients had neoadjuvant chemotherapy/radiation prior to surgical
treatment, followed by adjuvant treatments after surgical reconstruction. Seven patients
with chondrosarcoma were treated by limb sparing resection or limb amputation only.
These patients did not receive chemotherapy or radiation. Osteosarcoma was diagnosed
in sixteen patients and they were treated with cisplatin and doxorubicin, or MAP (high
dose methotrexate, cisplatin and doxorubicin), or doxorubicin, cisplatin, ifosfamide and
high dose methotrexate, or ifosfamide, cisplatin and epirubicin prior and post to surgical
treatments.
The nine Ewing sarcoma patients had neoadjuvant and adjuvant VAC/IE
(vincristine, doxorubicin, and cyclophosphamide alternating with ifosfamide and
etoposide), or VAI (vincristine, doxorubicin, and ifosfamide), or VIDE (vincristine,
doxorubicin, ifosfamide, and etoposide) as the primary chemotherapy treatment.
Local Recurrences
Local recurrences occurred in 12% (6 patients: n=5 limb salvage and n=1
amputation) leading to revisions. Five patients (10%) had prior exposure to radiation
therapy for their sarcoma and then limb salvage reconstruction, n=2 had malignant
peripheral sheath sarcoma and n=2 had neurofibrosarcoma. These patients were in
remission for over 20 years. One patient (2%) had radiation induced pleomorphic
sarcoma. The patient had received radiation treatment 30 years prior. Amputation was
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performed in all the patients following recurrence. The decision to amputate was solely
based on soft tissue complications such as encasement of nerves or neurovascular bundle
by tumor. The recurrences occurred around the same site as the primary tumor. One
patient (2%) had a primary below knee amputation but when the tumor recurred, an
above knee amputation was performed. More patients in the limb salvage group (p <0.05)
had local recurrence of tumor than the amputation group. The risk factors for recurrences
were radiation and limb salvage.
Table 3.0. Comparison of local recurrence
Group

Local recurrence
Yes

No

Limb salvage

5 (10%)

14 (28%)

Amputation

1(2%)

24 (48%)

Complications
Complications occurred in all 50 patients and included infection, revision
surgeries, physical limitations, cardiomyopathy, pain, and reproductive health issues.
Infection
Infection was reported in 10 patients (20%). The average time to infection was
immediately following reconstruction surgeries. There were two patients (4%) in the
amputation group who had non-healing wound which lead to infection. The infection was
at the amputation stump and led to chronic osteomyelitis. One of the patient`s wound was
infected with Staphylococcus Epidermis species. The patient was on a long course of
antibiotics (Augmentin) for 85 days. The non-healing wound was caused by skin edges
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overlapping and for some reason this caused a small area of pinpoint drainage which was
exacerbated by the use of prosthesis. The infection led to a surgical revision. Six patients
(12%) had infection of the megaprosthesis following limb salvage reconstruction. One
patient (2%), a 47-year-old had infection of megaprosthesis that ultimately led to above
the knee amputation. The decision to amputate was because the infection could not be
controlled. The incidence of infection was also reported in two patients (4%) who had
limb salvage reconstruction using bone allograft. These patients also had non-union of
bone allograft to bone. The infection of bone allograft led to bacteremia, sepsis and use of
antibiotics for at least 3 months.
Physical Limitations
Physical limitations were reported in 18 patients in the limb salvage group and 31
patients in the amputation group. The physical limitations ranged from minor such as
inability to fully extent and flex limb to major limitations such as walking up a steep hill.
The patients reported that they could not return to their baseline function before the
sarcoma diagnosis. Limb salvage patients were cautioned against participation in high
impact activities such as skiing or sprinting. Gait problems were experienced in the
amputation groups. Therefore, the pattern of physical limitations differed between the
two groups. For example, one patient had to relearn driving using her amputated limb
fitted with a prosthetic leg. A limb salvage patient had difficulties walking uphill or
downhill, performing household tasks such as mowing the lawn.
Pain
Pain was reported in all the patients in the limb salvage and amputation group
(n=50). Eight patients (16%) were on narcotics for management of the severe chronic
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pain. In the limb salvage group, pain was experienced especially at the knee or hip.
Phantom pain was experienced in 100% of the amputation patients. In severe cases,
patients used higher doses of Neurontin per day to reduce the pain sensation. One patient
required 900 mg Neurontin daily to help with the pain. Patients in the amputation group
also experienced pain or discomfort at the amputation stump.
Revisions
Revision surgeries occurred in all limb salvage reconstruction (n=19). The
revision surgeries ranged from two to five per patient. The number of surgeries a patient
had depended on the initial surgery, implant used and number of years post sarcoma
diagnosis. The reasons for revisions included implant loosening, infection, and fracture in
biological implants.
An example was a patient who had a total of 5 surgeries for osteosarcoma of the
proximal tibia. The patient was diagnosed 17 years ago at 15 years of age. Initial surgery
was limb salvage with wide excision and osteoarticular allograft reconstruction. Second
surgery was open reduction and internal fixation of the biological implant following
prosthetic fracture. The third surgery was knee arthroplasty for ongoing degenerative
changes, and then revision of knee arthroplasty. The most recent surgery was knee
manipulation under anesthesia.
Revision surgeries with amputation, n=25 were due to infection, removal of
nodule on amputation stump, wound revision, wound closure, stump ulceration, or
correction of stump deformity. The revision surgeries ranged from one to three. An
example is one patient who had a nodule at the site of the amputation stump, this tumor
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was excised. The patient had recurrence of the nodule two years later which required
surgical excision.
Complications in Pediatrics Sarcoma Patients
Twenty-four patients had osteosarcoma or Ewing sarcoma in childhood. Limb
salvage reconstruction was done using endoprosthesis and biological allografts.
Biological allograft was done in seven patients (14%), eight patients (16%) had
endoprosthesis for limb salvage and nine patients (18%) had amputation. Complications
in pediatric patients included: Need for lengthening of prosthetic legs in the amputation
group, leg length discrepancies in limb salvage group, ovarian dysfunction secondary to
chemotherapy, and risk for early menopause in females. An example is an Ewing
sarcoma patient who had below knee amputation when she was 13. When the patient
reached adulthood, her prosthetic leg had to be lengthened.
Chemotherapy/Radiation Induced Complications
Patients who were treated with doxorubicin, which is an anthracycline, were at
risk for cardiotoxicity. The number of patients with cardiomyopathy induced by
anthracycline treatment were n=3 (6%). The patients had subclinical left ventricular
dysfunction, reduced ejection fractions, and were followed closely by cardiology.
Sensorineural hearing loss was reported in one patient due to methotrexate exposure.
Pattern and Onset of Complications
Complications following treatments for extremity bone and soft tissue sarcoma
were evident soon after the treatments and would persist for years following the
treatments. Overall, the difference in complications of extremity bone and soft tissue
sarcoma was in the incidences of local recurrence. Limb salvage group had a greater
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recurrence rate compared to amputation. Infection was greatest in limb salvage
reconstruction compared to amputation.
Figure 1.0. Comparison of complications of extremity bone and soft tissue sarcoma
Comparison of complications of extremity bone and soft tissue
sarcoma
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Chapter 5: Discussion
Extremity bone and soft tissue sarcoma are a rare type of cancer whose treatment
modalities include chemotherapy and or radiation followed by limb salvage or
amputation reconstruction. Complications arise with both limb salvage and amputation.
Although early and late complications have been reported, there has been limited
research on the comparison complications of amputation and limb salvage procedures for
extremity bone and soft tissue sarcoma. A detailed analysis of these complications is still
needed. This research attempted to determine if 1) amputation reconstruction was
associated with greater complications than limb salvage and 2) if there was a difference
in post-surgical complications following limb salvage versus amputation.
Local Recurrence
Limb salvage reconstruction is favored compared to amputation because this type
of reconstruction may provide a functional and durable limb unlike in amputation
reconstruction (Levin et al., 2017). Limb salvage is preferred especially in young patients
who are expected to remain active. From the study limb salvage was associated with a
higher local recurrence than amputation. The results of this study showed that these
patients had received radiation therapy for their cancer many years before the recurrence.
This is important to note that even after 5 years of complete remission, the tumors can
recur due to the exposure to radiation therapy. Also, local recurrences in our patients may
have been attributed to inadequate resection margin. When local recurrence occurred, the
surgical decision was to amputate.
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Infection and Fracture in Limb Salvage Reconstruction
Endoprostheses implants are the most preferred reconstruction implants today
(Levin et al., 2017). One of the drawbacks of limb salvage is the eventual need for
revision reconstruction. Patients in our study all had revision reconstruction. Revisions
occurred because of prosthetic fracture, prosthetic loosening, infection, pain, or physical
limitations. Patients who had limb salvage using bone allograft all experienced
complications due to infection, non-union of bone allograft to bone leading to fracture.
Loosening and infection of implant are the most common complications with limb
salvage reconstruction (Biau, Faure, & Katsahian, 2006). When an infection occurs in a
endoprosthesis, the implant has to be revised and often leads to amputation if the
infection cannot be controlled. Rates of infection of megaprosthesis have been reported to
be 2.2% (Torbert, Fox, & Hosalkar, 2005). This study infection rates for limb salvage
were 16% and much higher than reported in literature. As stated earlier in the literature
review, the most common specie responsible for infection are Staphylococci and
Streptococci (Lee et al., 2002). In addition, when patients are receiving chemotherapy
treatments, they are susceptible to opportunistic infections (Papanastasiou et al., 2017).
Pattern and Onset of Complications
Pain was reported in all patients regardless of the type of reconstruction. Pain was
inevitable due to stiffness of the implant, limited range of motion with limb salvage
reconstruction or pain at the amputation site due to stump ulceration, benign nodules, or
non-healing amputation wound. Complications arising from amputation after limb
salvage were similar to those when amputation was done as the initial treatment. The
patients had issues with phantom pain and physical limitations.
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Cardiotoxicity is associated with the use of anthracyclines, like doxorubicin,
daunorubicin and epirubicin (Van Dalen, Raphaël, Caron, & Kremer, 2014). These
chemotherapy drugs are used in bone sarcoma treatment protocols. This study showed
that patients who had cardiomyopathy induced by anthracyclines were diagnosed and
treated for osteosarcoma when they were children. Anthracycline-induced cardiotoxicity
is widely reported in children (Van Dalen et al., 2014). Cardiotoxicity can lead to long
term morbidity and reduction in quality of life. The damage to the heart may occur as
heart failure or asymptomatic dysfunction of the heart that is found on imaging such as
echocardiogram.
Limitations
There were limitations to the chart review study. First the number of patients were
small (n=50). This was expected because of the rareness of extremity bone and soft tissue
sarcoma. Second, this study did not determine if the complications improved as the
number of years post diagnosis increased. However, there were patients who continued to
have more problems many years post diagnosis. To better understand the complications,
conducting surveys using standardized instruments would be ideal especially when trying
to gather information about physical limitations. These standardized instruments would
include Quality of Life-Cancer Survivor Score (QLS-CS), Toronto Extremity Salvage
Score (TESS), Musculoskeletal Tumor Society (MSTS). Third, this study was a
retrospective study of patients treated over a long period of time with some patient
records not current.
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Summary
Limb salvage reconstruction was associated with greater local recurrence than the
amputation group. However, the patients had received radiation therapy > 20 years ago
for their primary tumor which may have increased recurrence rates. Infection was
reported more with limb salvage reconstruction than amputation. Therefore, amputation
was not associated with greater complications than limb salvage. Overall, the postsurgical complications in the amputation group and limb salvage were similar. This study
was important in order to better understand the complications sarcoma patients face
following treatments and to better find ways to offer support. Clinicians can use this
information to better tailor treatments to the cancer patients.
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Research that involves observation can be approved under this category without
obtaining consent.

SURVEY OR INTERVIEW RESEARCH APPROVED AS EXEMPT UNDER THIS
CATEGORY IS LIMITED TO ADULT SUBJECTS.
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Demographic data
Patient Study ID#______________
Patient Name_________________________________
First/Middle/Last
Date of Birth_____________________________________
Month/Day/Year
Age of Patient at time of diagnosis_____________________
Diagnosis: __________________

(years)

Date of Diagnosis: _________________
Month/ Day/Year
Tumor Site: Bone: 1) pelvis, 2) proximal femur, 3) distal femur, 4) proximal tibia, 5)
distal
tibia, 6) proximal fibula, 7) distal fibula, 8) proximal humerus, 9) distal humerus,
10) forearm bone (radius or ulna) 11) hand bone, 12) ankle or foot bone
13) other______________________
Soft Tissue: 1) buttock, 2) thigh, 3) leg (below knee), 4) hindfoot, 5)
midfoot/forefoot , 6) arm, 7) forearm (below elbow), 8) hand/wrist,
9) other________________________
Treatment: Surgical procedure:
1) Bone Reconstruction: prosthesis, structural allograft bone graft
2) Soft Tissue Reconstruction: muscle flap, skin graft
3) Amputation: 1) partial foot, 2) below knee, 3) above knee, 4) at knee, 5) hip
disarticulation,
6) hemipelvectomy, 7) below elbow, 8) above elbow, 9) shoulder girdle
Surgery (tumor excision and/or reconstruction) date: ___________________
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Month/ Day/Year
Chemotherapy: Cytotoxic drugs______________________________________
Total duration of chemotherapy (months) ______________________
Radiation: Total Dose (Gy) ___________________
Total duration of radiation (month): _______________
Additional Surgery: ________________________
Date of additional surgery: ____________________

